Characteristics | Â | % or (IQR) | [n] |
---|---|---|---|
N, no | 133 | Â | Â |
Age, median | 70 | (62.0–77.0) | [133] |
Sex Male, no | 87 | 65.4% | [133] |
BMI (kg/m2), median | 22.8 | (20.9–24.7) | [133] |
History of smoking, no | 76 | 61.8% | [123] |
Brinkman index, median | 900 | (500–1393) | [81] |
Pulmonary function test | |||
 %VC, median (%) | 110.7 | (100.9–120.6) | [103] |
 FEV1/FVC, median (%) | 73.9 | (64.7–77.6) | [103] |
 %DLCO, median (%) | 88.6 | (75.7–105.7) | [98] |
KL-6, median (U/mL) | 234 | (169.5–321) | [81] |
Orgnization type of lung cancer | |||
 Adenocarcinoma, no | 99 | 74.4% | [133] |
 Squamous cell carcinoma, no | 24 | 18.0% | [133] |
 Small cell caricnoma, no | 4 | 3.0% | [133] |
 LCNEC, no | 4 | 3.0% | [133] |
  Adenosquamous cell carcinoma, no | 2 | 1.5% | [133] |
Tumor size (mm) | 23 | (15–32.5) | [133] |
pT classification, no (T3, T4) | 28 | 26.4% | [133] |
pN classification, no (N1, N2) | 23 | 17.3% | [133] |
pM classification, no (M1) | 2 | 1.5% | [133] |
pStage | |||
 I | 100 | 77.4% | [133] |
 II | 19 | 14.2% | [133] |
 III | 12 | 7.6% | [133] |
 IV | 2 | 0.9% | [133] |